Back to
Allianz Asset Management GmbH
VIVO
Showing 0 of 10 quarters
Position history for
Allianz Asset Management GmbH's holdings in MERIDIAN BIOSCIENCE INC
No. Allianz Asset Management exited its VIVO (Meridian Bioscience) position in Q3 2022. Its Q2 2022 13F listed 16,384 shares worth $498,000. Allianz Asset Management first reported VIVO in Q2 2020 and held it in 9 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.